Establishment Labs Begins Trading on the NASDAQ

- July 19th, 2018

Establishment Labs Holdings (NASDAQ:ESTA) has announced that its common stock has begun trading on the NASDAQ. As quoted in the press release: Establishment Labs is a global medical technology company focused on breast aesthetics and reconstruction technologies. Founder and Chief Executive Officer Juan José Chacón-Quirós, joined by members of the company’s management team and family, … Continued

Establishment Labs Holdings (NASDAQ:ESTA) has announced that its common stock has begun trading on the NASDAQ.

As quoted in the press release:

Establishment Labs is a global medical technology company focused on breast aesthetics and reconstruction technologies.

Founder and Chief Executive Officer Juan José Chacón-Quirós, joined by members of the company’s management team and family, celebrated the company’s first day of trading by visiting the exchange.

“Today’s listing on Nasdaq represents a significant milestone for Establishment Labs and our shareholders,” said Mr. Chacón-Quirós. “It’s an honor to be the first company headquartered in Costa Rica to be listed on a major stock exchange in the United States.”

“We welcome Establishment Labs to the Nasdaq family, and look forward to supporting their continued success,” said Joe Brantuk, Vice President of Nasdaq. “Establishment Labs continuously works to improve patient safety and aesthetic outcomes while simultaneously working towards its entry into the U.S. market.”

Click here to read the full press release.

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Tags

Leave a Reply